Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thomson

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Interventional Pain Medicine|September 6, 2024
Real-world outcomes of single-stage spinal cord stimulation in chronic pain patients: A multicentre, European case seriesPasquale De Negri, Jose Francisco Paz-Solis, Philippe Rigoard, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study)Krishna Kumar, Richard North, Rod Taylor, et al.
BMJ Open|June 17, 2024
Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematomaSarah Pyne, Garry Barton, David Turner, et al.
Pain|January 20, 2021
Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendationsNathaniel Katz, Robert H Dworkin, Richard North, et al.
Trials|December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials|March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 13, 2014
The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus CommitteeTimothy R Deer, Nagy Mekhail, David Provenzano, et al.
Neuro-Oncology Advances|May 31, 2021
CovidNeuroOnc: A UK multicenter, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology serviceDaniel M Fountain, Rory J Piper, Michael T C Poon, et al.
The New England Journal of Medicine|December 16, 2020
Trial of Dexamethasone for Chronic Subdural HematomaPeter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Scientific Reports|April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phaseEllie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Interventional Pain Medicine|September 6, 2024
Real-world outcomes of single-stage spinal cord stimulation in chronic pain patients: A multicentre, European case seriesPasquale De Negri, Jose Francisco Paz-Solis, Philippe Rigoard, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study)Krishna Kumar, Richard North, Rod Taylor, et al.
BMJ Open|June 17, 2024
Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematomaSarah Pyne, Garry Barton, David Turner, et al.
Pain|January 20, 2021
Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendationsNathaniel Katz, Robert H Dworkin, Richard North, et al.
Trials|December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials|March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 13, 2014
The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus CommitteeTimothy R Deer, Nagy Mekhail, David Provenzano, et al.
Neuro-Oncology Advances|May 31, 2021
CovidNeuroOnc: A UK multicenter, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology serviceDaniel M Fountain, Rory J Piper, Michael T C Poon, et al.
The New England Journal of Medicine|December 16, 2020
Trial of Dexamethasone for Chronic Subdural HematomaPeter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Scientific Reports|April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phaseEllie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Pageof 11